Page last updated: 2024-10-21

14,15-epoxy-5,8,11-eicosatrienoic acid and Asthma

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Asthma in 1 studies

14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research Excerpts

ExcerptRelevanceReference
"The effect of AUDA on airway remodeling was related to the downregulation of extracellular-regulated protein kinases (Erk1/2), c-Jun N-terminal kinases (JNK) and signal transducer and activator of transcription 3 (STAT3)."1.56Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model. ( Guan, Y; Jia, YL; Jiang, JX; Liu, Q; Shen, HJ; Shen, J; Xie, QM; Zhang, LH; Zhu, YL, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jiang, JX1
Guan, Y1
Shen, HJ1
Jia, YL1
Shen, J1
Zhang, LH1
Liu, Q1
Zhu, YL1
Xie, QM1

Other Studies

1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Asthma

ArticleYear
Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model.
    European journal of pharmacology, 2020, Feb-05, Volume: 868

    Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Airway Remodeling; Animals; Asthma; Bronchoalveolar Lavage

2020